{"id":"https://openalex.org/W4385457828","doi":"https://doi.org/10.1158/0008-5472.23814627.v1","title":"Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway","display_name":"Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4385457828","doi":"https://doi.org/10.1158/0008-5472.23814627.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.23814627.v1","doi":"https://doi.org/10.1158/0008-5472.23814627.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.23814627.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.23814627.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021164025","display_name":"Michael P. Ludwig","orcid":"https://orcid.org/0009-0002-5961-1490","observed_orcids":["https://orcid.org/0009-0002-5961-1490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael P. Ludwig","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-5961-1490","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026150976","display_name":"Matthew D. Galbraith","orcid":"https://orcid.org/0000-0003-0485-3927","observed_orcids":["https://orcid.org/0000-0003-0485-3927"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew D. Galbraith","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0485-3927","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058939331","display_name":"Neetha Paul Eduthan","orcid":"https://orcid.org/0009-0002-6351-0051","observed_orcids":["https://orcid.org/0009-0002-6351-0051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neetha Paul Eduthan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-6351-0051","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076866502","display_name":"Amanda A. Hill","orcid":"https://orcid.org/0009-0009-9392-1717","observed_orcids":["https://orcid.org/0009-0009-9392-1717"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda A. Hill","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-9392-1717","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001478843","display_name":"Michael R. Clay","orcid":"https://orcid.org/0000-0003-1659-8927","observed_orcids":["https://orcid.org/0000-0003-1659-8927"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael R. Clay","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1659-8927","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063576155","display_name":"Cristiam Moreno Tellez","orcid":"https://orcid.org/0000-0001-8064-0865","observed_orcids":["https://orcid.org/0000-0001-8064-0865"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristiam Moreno Tellez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8064-0865","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004799762","display_name":"Breelyn Ann Wilky","orcid":"https://orcid.org/0000-0001-5080-497X","observed_orcids":["https://orcid.org/0000-0001-5080-497X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Breelyn A. Wilky","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5080-497X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091848952","display_name":"ANTHONY D. ELIAS","orcid":"https://orcid.org/0000-0002-6509-9211","observed_orcids":["https://orcid.org/0000-0002-6509-9211"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Elias","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6509-9211","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060639948","display_name":"Joaquin Maximiliano Espinosa","orcid":"https://orcid.org/0000-0001-9048-1941","observed_orcids":["https://orcid.org/0000-0001-9048-1941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joaquin M. Espinosa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9048-1941","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027320272","display_name":"Kelly D. Sullivan","orcid":"https://orcid.org/0000-0003-2725-0205","observed_orcids":["https://orcid.org/0000-0003-2725-0205"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly D. Sullivan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2725-0205","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.8544999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.8544999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.04560000076889992,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.022099999710917473,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.8870000243186951},{"id":"https://openalex.org/keywords/liposarcoma","display_name":"liposarcoma","score":0.9179999828338623},{"id":"https://openalex.org/keywords/mdm2-inhibition","display_name":"MDM2 inhibition","score":0.9850000143051147},{"id":"https://openalex.org/keywords/nutlin-3","display_name":"Nutlin-3","score":0.8700000047683716},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress-response","display_name":"endoplasmic reticulum stress response","score":0.9049999713897705},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.733702540397644},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.6982792019844055},{"id":"https://openalex.org/C2780900454","wikidata":"https://www.wikidata.org/wiki/Q21102119","display_name":"ATF4","level":4,"score":0.643375039100647},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5880087018013},{"id":"https://openalex.org/C139447449","wikidata":"https://www.wikidata.org/wiki/Q14633900","display_name":"Unfolded protein response","level":3,"score":0.41733455657958984},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3539149761199951},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3516695499420166},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2940486669540405},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.10410651564598083},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.09556862711906433},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08315715193748474}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.23814627.v1","doi":"https://doi.org/10.1158/0008-5472.23814627.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.23814627.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/23814627","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_File_5_from_Proteasome_Inhibition_Sensitizes_Liposarcoma_to_MDM2_Inhibition_with_Nutlin-3_by_Activating_the_ATF4_CHOP_Stress_Response_Pathway/23814627","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.23814627.v1","doi":"https://doi.org/10.1158/0008-5472.23814627.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.23814627.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9074000120162964,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.5,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4295500741","https://openalex.org/W2611930797","https://openalex.org/W2012324519","https://openalex.org/W2982608195","https://openalex.org/W3011610264","https://openalex.org/W2028279477","https://openalex.org/W3033952972","https://openalex.org/W2063229389","https://openalex.org/W2014194571","https://openalex.org/W4213112933"],"abstract_inverted_index":{"Nutlin-3-proteasome":[0],"inhibitor":[1],"drug":[2],"interaction":[3],"SRB":[4],"data.":[5]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}